BioCentury
ARTICLE | Clinical News

TherapeuticsMD submits NDA for TX-001HR to treat menopause symptoms

January 5, 2018 5:40 PM UTC

TherapeuticsMD Inc. (NYSE-M:TXMD) submitted an NDA to FDA for TX-001HR estradiol/progesterone to treat moderate to severe vasomotor symptoms due to menopause. The candidate is an oral combination cap...

BCIQ Company Profiles

TherapeuticsMD Inc.